Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2024-04-01

Research Network

Collaboration Network

106 collaborators·150 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hebei Medical University Third Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score15%

Yimin Mao

RenJi Hospital

Related
4 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Peng Hu

The Second Affiliated Hospital of Chongqing Medical University

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score15%

Jianwei Yang

Fujian Cancer Hospital

Related
3 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Xiaoyan Wang

The Third Xiangya Hospital of Central South University

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score15%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score15%

Liaoyun Zhang

The First Affiliated Hospital of Shanxi Medical University

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Chengwei Chen

No.85 hospital of PLA

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06272656PrincipalInvestigator

Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma

Hepatocellular Carcinoma
Unknown
NCT02961413PrincipalInvestigator

A Prospective Cohort Study on Drug-induced Liver Injury in China(DILI-P)

Drug-induced Liver Injury
Recruiting

All 2 trials loaded